Logo
Search for

Volume 52, Issue 4, Pages 347-361 (January 2010)


View previous. 13 of 13

Amyloid Heart Disease

Rodney H. FalkaCorresponding Author Informationemail address, Simon W. Dubreyb

Refers to erratum:
Erratum to vol 52, no. 4, Jan/Feb 2010
Progress in Cardiovascular Diseases
March 2010 (Vol. 52, Issue 5, Pages 445-447)
Full Text | Full-Text PDF (1245 KB)

Abstract 

The systemic amyloidoses are an uncommon group of disorders characterized by the extracellular deposition of amyloid in one or more organs. Cardiac deposition, leading to an infiltrative/restrictive cardiomyopathy, is a common feature of amyloidosis. It may be the presenting feature of the disease or may be discovered while investigating a patient presenting with non-cardiac amyloidosis. In this article we review the features of cardiac amyloidosis and its varied manifestations. The need for a high index of suspicion and the critical importance of precise biochemical typing of the amyloid deposits is stressed in light of recent advances in therapy which can, when appropriately used, significantly improve prognosis.

a Harvard Vanguard Medical Associates, Harvard Medical School, Boston, MA, USA

b Hillingdon Hospital Uxbridge, United Kingdom

Corresponding Author InformationAddress reprint requests to Rodney H. Falk, MD, Harvard Vanguard Medical Associates 133, Brookline Ave, Boston, MA 02215.

 Statement of Conflict of Interest: see page 358.

PII: S0033-0620(09)00097-8

doi:10.1016/j.pcad.2009.11.007


View previous. 13 of 13